A tech giant is offering a free hand to healthcare experts working in various fields that could be tapping tireless AI rather than overworked humans to answer questions from the general public on COVID-19.

The images are rendered from CT scans and allow viewers to navigate the lungs in 360-degree tours, as demonstrated in a video podcast posted by George Washington University Hospital.

Researchers have used machine learning to develop a blood test that can find 50 or so types of cancer.

A disease that hits most people mildly but some very hard—and so wreaks havoc with its unpredictability among the infected—would seem a good target for AI’s predictive prowess.

Researchers in South Korea have shown that AI trained on photos of both Asian and Caucasian patients can help dermatologists more accurately diagnose many diseases and disorders of the skin in both subpopulations.

A healthcare AI company has spotted several unexpected, off-label drug combinations that may do the job against COVID-19. In any case, the company is offering its complete AI toolkit free of charge to drug developers working on COVID treatments.

When Windy City residents send out tweets containing the term “food poisoning,” an algorithm offers a form for sharing details with Chicago’s public-health officials. Why not do the same with keywords like “cough,” “fever” and “trouble breathing” to help track COVID-19?

The Finnish maker of the Oura health-tracking finger ring is sponsoring a two-pronged, AI-aided COVID-19 study at the University of California, San Francisco (UCSF).